Skip to main content

A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

OCS Liver PROTECT Continued Access Protocol

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about OCS Liver PROTECT Continued Access Protocol

STRIVE Post-Market Registry Study

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about STRIVE Post-Market Registry Study

Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer (LIGHTHOUSE)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer (LIGHTHOUSE)

A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia

A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy

Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 (PD-L1) Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 (PD-L1) Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Evaluation of the Asthma Management Program to Promote Activity for Students in Schools (Asthma-PASS)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Evaluation of the Asthma Management Program to Promote Activity for Students in Schools (Asthma-PASS)

Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery

Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 80
  • Page 81
  • Page 82
  • Page 83
  • Page 84
  • Page 85
  • Page 86
  • Page 87
  • Page 88
  • …
  • Next page Next
  • Last page Last
Subscribe to